• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)

    9/30/25 10:20:00 AM ET
    $CVS
    $VRT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Industrial Machinery/Components
    Technology
    Get the next $CVS alert in real time by email

    TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE:VRT) as worthy of further study and has named the company its "Stock to Study" for the December 2025 issue for investors' informational and educational use.

    The fundamental data is eye-opening; investors can view Vertiv's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/study/ssgplus/?studyid=17125916.

    A full report on Vertiv will appear in the December 2025 issue of BetterInvesting Magazine. 

    The same issue of BetterInvesting Magazine will also include a fundamental review of CVS Health Corp. (NYSE:CVS), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

    Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

    Doron P. Levin, an editor of the magazine, serves as the committee's chairperson.

    Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

    About BetterInvesting:

    BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

    Follow us on LinkedIn, Instagram and Facebook.

    Contact: 877-275-6242

    Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-vertiv-holdings-co-nyse-vrt-and-cvs-health-corp-nyse-cvs-302571020.html

    SOURCE National Association of Investors/BetterInvesting

    Get the next $CVS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $VRT

    CompanyDatePrice TargetRatingAnalyst
    Vertiv Holdings LLC
    $VRT
    8/20/2025$135.00Neutral
    Rothschild & Co Redburn
    CVS Health Corporation
    $CVS
    8/18/2025$79.00Neutral → Buy
    UBS
    CVS Health Corporation
    $CVS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    Vertiv Holdings LLC
    $VRT
    7/28/2025Outperform
    William Blair
    Vertiv Holdings LLC
    $VRT
    7/8/2025$165.00Hold → Buy
    Melius
    Vertiv Holdings LLC
    $VRT
    4/8/2025$75.00Buy
    ROTH MKM
    Vertiv Holdings LLC
    $VRT
    3/7/2025$121.00Outperform
    RBC Capital Mkts
    CVS Health Corporation
    $CVS
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    More analyst ratings

    $CVS
    $VRT
    SEC Filings

    View All

    SEC Form 8-K filed by CVS Health Corporation

    8-K - CVS HEALTH Corp (0000064803) (Filer)

    9/22/25 4:19:42 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    9/8/25 4:59:27 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Vertiv Holdings LLC filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Vertiv Holdings Co (0001674101) (Filer)

    9/3/25 6:38:59 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)

    TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE:VRT) as worthy of further study and has named the company its "Stock to Study" for the December 2025 issue for investors' informational and educational use. The fundamental data is eye-opening; investors can view Vertiv's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/study/ss

    9/30/25 10:20:00 AM ET
    $CVS
    $VRT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Industrial Machinery/Components
    Technology

    CVS Health to hold third quarter 2025 earnings conference call

    WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025,

    9/30/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Vertiv with a new price target

    Rothschild & Co Redburn initiated coverage of Vertiv with a rating of Neutral and set a new price target of $135.00

    8/20/25 9:03:10 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded CVS Health from Neutral to Outperform and set a new price target of $82.00

    8/14/25 8:02:24 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CVS
    $VRT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Mahoney Michael F bought $2,001,000 worth of shares (30,000 units at $66.70), increasing direct ownership by 321% to 39,356 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    2/19/25 12:35:35 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Ludwig Edward J bought $53,879 worth of shares (1,000 units at $53.88), increasing direct ownership by 5% to 21,630 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    5/2/24 4:31:44 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Chief Human Resources Officer Poncheri Frank was granted 1 shares, increasing direct ownership by 0.02% to 8,265 units (SEC Form 4)

    4 - Vertiv Holdings Co (0001674101) (Issuer)

    9/26/25 4:11:08 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Chief Procurement Officer Ryan Paul was granted 2 shares, increasing direct ownership by 0.01% to 12,805 units (SEC Form 4)

    4 - Vertiv Holdings Co (0001674101) (Issuer)

    9/26/25 4:11:02 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Chief Legal Counsel & Sec. Gill Stephanie L was granted 6 shares, increasing direct ownership by 0.02% to 27,462 units (SEC Form 4)

    4 - Vertiv Holdings Co (0001674101) (Issuer)

    9/26/25 4:10:55 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Financials

    Live finance-specific insights

    View All

    CVS Health to hold third quarter 2025 earnings conference call

    WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025,

    9/30/25 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health declares quarterly dividend

    WOONSOCKET, R.I., Sept. 17, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on November 3, 2025, to holders of record on October 23, 2025. About CVS HealthCVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of June 30, 2025, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and prima

    9/17/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Vertiv Declares Quarterly Dividend

    COLUMBUS, Ohio, Sept. 3, 2025 /PRNewswire/ -- Vertiv Holdings Co (NYSE:VRT), a global leader in critical digital infrastructure, today announced that its Board of Directors has declared a quarterly cash dividend of $0.0375 per share of the company's Class A common stock. The cash dividend will be payable on September 25, 2025, to shareholders of record of Class A common stock at the close of business on September 15, 2025. About Vertiv Holdings Co Vertiv (NYSE:VRT) brings together hardware, software, analytics and ongoing services to enable its customers' vital applications to

    9/3/25 6:30:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Leadership Updates

    Live Leadership Updates

    View All

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Vertiv Appoints Wei Shen as President of Greater China

    COLUMBUS, Ohio, July 21, 2025 /PRNewswire/ -- Vertiv (NYSE:VRT), a global leader in critical digital infrastructure, today announced the appointment of Wei Shen as president of Greater China, effective July 22, 2025. Shen joins Vertiv from Gates Corporation, where he served as vice president, general manager – Greater China for nine years. Prior to Gates Corporation, he held several leadership positions at Eaton Electrical, including vice president, general manager of distributed power quality for APAC, vice president of sales operations and power quality marketing APAC, and b

    7/21/25 10:45:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Vertiv Names Mike Giresi as Global CIO

    Giresi to further reinforce Vertiv's digital and AI strategy, in support of executional strength, superior customer experience and operational leverage COLUMBUS, Ohio, June 3, 2025 /PRNewswire/ -- Vertiv (NYSE:VRT), a global leader in critical digital infrastructure, today announced that Mike Giresi will join the company on June 30, 2025 as global Chief Information Officer (CIO), leading company initiatives in AI adoption across the business, cybersecurity, product security, and digital enabled productivity and customer experience. "Strong digital and IT vision and execution a

    6/3/25 7:30:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Vertiv Holdings LLC

    SC 13G - Vertiv Holdings Co (0001674101) (Subject)

    11/13/24 4:34:55 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Vertiv Holdings LLC

    SC 13G/A - Vertiv Holdings Co (0001674101) (Subject)

    11/12/24 5:49:48 PM ET
    $VRT
    Industrial Machinery/Components
    Technology